Park Medi World Limited has informed the Exchange about Transcript

Park Medi World Limited reported its best-ever annual performance for FY'26 with revenue of INR 1,679 crores (up 21% YoY), EBITDA of INR 444 crores (margin 26%), and PAT of INR 274 crores (up 27% YoY, margin 16%). Q4 FY'26 was particularly strong with 30% revenue growth to INR 460 crores and 47% PAT growth to INR 77 crores. The company expanded its network to 16 hospitals with 3,960 beds after adding 610 beds in FY'26 through new units in Bathinda (250 beds) and Agra (360 beds), plus a Panchkula Greenfield (350 beds, commissioned April 2026) and an acquired Narela facility (200 beds, commissioning Q2 FY'27). The balance sheet is exceptionally strong with gross debt reduced to INR 28 crores from INR 450 crores, cash and FDs of INR 352 crores, and operating cash flow of INR 329 crores. Management targets 5,460 bed capacity by March 2028 with 1,500 beds under execution and capex of ~INR 500 crores over the next two years, fully funded from internal generation. CGHS rate hike benefits (12-15% increase) are expected to contribute ~5-6% to FY'27 revenue while offsetting any margin pressure from new unit ramp-ups. Occupancy improved to 64.1% for FY'26 (from 61.7% in FY'25) and ARPOB grew 7% to INR 28,000.